ReviewMetabolic engineering communications2026
Metabolic engineering for tobacco quality improvement: Advances and perspectives.
Review in Metabolic engineering communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As a major cash crop, tobacco quality improvement is constrained by the limited effectiveness of conventional approaches, including traditional breeding and agronomic regulation. This review focuses on the application of metabolic engineering to enable precise and targeted modulation of tobacco quality traits. We first analyze the key factors and underlying mechanisms governing aroma, health-related components, functional metabolites, and combustion characteristics. We then summarize recent advances in metabolic engineering strategies, including pathway rewiring, metabolic flux redistribution, enzyme engineering, and regulatory-network modulation, for optimizing the biosynthesis and accumulation of target compounds such as terpenoids, polyphenols, and alkaloids. In addition, selected integrative approaches that support metabolic regulation and quality formation are briefly discussed. Finally, we highlight current challenges and outline future research directions to facilitate more precise and efficient improvement of tobacco quality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.